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Transplantation assays suggest that multipotent stem cells maintain the two lineages of themammary gland.
Recently in Nature, Van Keymeulen et al. (2011) used lineage tracing to discover unipotent stem cells that
maintain the bulk of the mouse mammary gland after birth and during pregnancy.Themammary gland undergoes extensive
development following birth, from glan-
dular expansion during puberty to full
lobuloalveolar differentiation for lactation.
Two main cell lineages are present within
mammary epithelium: luminal cells that
line the interior of ducts and alveoli and
express hormone receptors and cytoker-
atins (CKs) 8, 18, and 19, and contractile
basal/myoepithelial (ME) cells, which are
localized between the luminal cells and
the basement membrane and express
smooth muscle actin (SMA), as well as
CKs 5 and 14. The luminal lineage also
encompasses the terminally differenti-
ated cells of the lobuloalveolar units,
which secrete milk during lactation.
The enormous cellular output needed
to meet the regenerative demands of suc-
cessive pregnancies and lactations sug-
gests the presence of multipotent stem
cells that sustain the two lineages (Fig-
ure 1A). However, a recent study by Van
Keymeulen, Blanpain, and colleagues
has radically revised our understanding
of the established hierarchy of the adult
mammary gland by suggesting that, un-
like other ‘‘renewable’’ epithelial tissues
known to be maintained by multipotent
stem cells (e.g., skin or intestine), the
mammary gland is maintained by two
separate populations of unipotent pro-
genitor cells (Van Keymeulen et al., 2011).
Current models of the mammary
epithelial hierarchy derive mainly from
studies that have used transplantation of
dissociated epithelial cells into fat pads
cleared of endogenous epithelium. Multi-
potent progenitor cells have been de-
scribed that contribute to ductal and
alveolar morphogenesis and exhibit self-
renewal properties in serial transplanta-
tions based on either CD24Med/CD29Hi496 Cell Stem Cell 9, December 2, 2011 ª20or CD24+/CD49fHi immunophenotypes
(Shackletonet al., 2006;Stingl et al., 2006),
or based on genetically marked cells that
emerge during pregnancy to contribute
to alveolar development (parity-induced
cells; Wagner et al., 2002). In their study,
Van Keymeulen and colleagues used an
inducible genetic linage tracing strategy
to study the progenitor behavior of cells
at defined time points: embryogenesis,
after birth, during puberty, and through
multiple lactations. Stem/progenitor ac-
tivity was monitored by YFP expressed
by lineage-specific cytokeratin promoters
in either basal/ME or luminal cells after
induction by doxycycline or tamoxifen
administration. Embryonic induction of
YFP controlled by the CK14 promoter
demonstrated that all cells in the mam-
mary gland were derived from an initial
CK14+ population, confirming previous
reports localizing multipotent progenitors
to the basal/ME lineage (Visvader, 2009).
However, when induced during puberty,
CK14 promoter-driven YFP marked only
CK14+/SMA+ myoepithelial cells and not
CK8+/CK19+ luminal cells. Similar results
were seen when YFP expression was in-
duced at puberty by CK5 promoter ac-
tivity. In contrast, when CK8 and CK18
promoters were used to drive YFP ex-
pression at puberty, only CK8+/CK19+
luminal lineage cells were marked. Taken
together, these results indicate that line-
age restriction is established shortly fol-
lowing birth. Low-dose treatment with
doxycycline or tamoxifen to label isolated
CK14+ or CK8+ cells, followed by several
rounds of pregnancies, indicated that
lineage-restricted progenitors were main-
tained and were able to clonally expand
through lactation and involution; labeled
CK18+ cells did not clonally expand, indi-11 Elsevier Inc.cating that CK18 may mark more differen-
tiated cells.
This provocative study provides the first
in situ evidence that facultative luminal
and basal/ME cell progenitors exist and
that together, they meet the regenerative
potential of the adult mammary gland.
Additionally, while not completely ruling
out the presence of rare multipotent
stem cells, it suggests that in adult mice,
these cells do not contribute significantly
to the maintenance of the gland. There
are some limitations to the study. A com-
plete lineage trace of the luminal epithe-
lium during embryonic development was
not performed, so it is unclear whether
CK8+ cells, or likely, a dual positive cell
is contributing to the formation of both
lineages in early development. Addition-
ally, clonal analyses would have been
strengthened if they had been performed
in combination with a marker of prolifera-
tion to support evidence for expansion
of the normally quiescent myoepithelial
layer. Nevertheless, these results revise
our thinking about the mouse mammary
hierarchy (Figure 1B).
But what are we to make of the wealth
of evidence for multipotent progenitors
from cleared fat pad transplantation stud-
ies and in vitro colony forming assays? In
this study, the authors demonstrated that,
while endogenous CK14+ and CK8+ cells
were lineage restricted, when trans-
planted into cleared mammary fat pads
alone or in an excess of CD24+CD29Lo
luminal cells, the CD24+CD29Hi fraction
(enriched in CK14+ cells) was able to
regenerate the mammary tree and con-
tributed to both the luminal and basal/
ME lineages. However, when YFP+
basal/ME cells were transplanted along
with unmarked luminal cells from glands
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Figure 1. Rethinking the Mouse Mammary
Hierarchy
(A) Classical model of mammary differentiation (Visvader,
2009) wherein a common progenitor cell maintains two
lineage-specific progenitors as well as alveolar progeni-
tors. Alveolar progenitors have also been proposed to
have bipotent potential during pregnancy (dashed arrow).
(B) Revised model of mammary differentiation (Van Key-
meulen et al., 2011) in which bipotent progenitors only
participate in embryonic development of the gland or are
reactivated during transplantation of basal/ME progenitors
(dashed arrow); luminal and basal/ME lineages are main-
tained by self-renewing unipotent progenitors in adults.
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Previewswhere YFP was induced in CK14-
expressing cells at puberty, the YFP+
CK14+ cells were once again
restricted to the regeneration of only
basal/ME cells. These results suggest
that CK14+ basal/ME cells retain the
potential to revert to a bipotent ‘‘em-
bryonic mode’’ under certain con-
ditions. Similar phenomenon have
been seen in other tissues where sep-
arate pools of stem cells can have
different roles depending on whether
they are contributing to homeostatic
maintenance or are enhancing regen-
eration in response to injury or in a
transplantation assay (Barker et al.,
2010). Likewise, Van Keymeulen et al.
suggest that eitherCK14+cells canbe
called upon to adopt multipotent
behavior or that dormant multipotent
cells are ‘‘reactivated’’ under condi-
tions of complete gland regeneration.
Hence, they suggest that caution is
warranted when assigning stem cell
activity to transplanted cells.
Lastly, what are the implications
of this study for our understanding
of the human breast hierarchy and
how it may influence cancer? Human
mammary glands have a more het-
erogeneous structure than their mu-
rine counterparts, with fibrous divi-
sions into lobules, which expand
during pregnancy and do not fully
regress following involution. Second,
although the murine mammary gland
has restricted basal/ME expression
of CK14 and luminal expression of
CK8/18, in the human gland, expres-sion is more varied. CK14 can be identi-
fied within luminal cells and can differ
significantly within the basal/ME cells of
lobules as compared with ducts; some
areas can even lack expression of both
types of keratins, suggesting that the
human mammary hierarchy is likely morecomplex (Petersen and Polyak, 2010).
For breast cancer, it is becoming evident
that lineage is both instructive and some-
what plastic for determining tumor pheno-
type. Evidence from mouse and human
tumor models suggests that luminal pro-
genitor cells may be the cells of originCell Stem Cell 9, Decfor basal-like breast tumors charac-
terized by expression of CK14 and
CK5, while basal/ME cells can adopt
dedifferentiated states to form meta-
plastic tumors that have lost identity
with breast tissue (Lim et al., 2009;
Molyneux et al., 2010; Keller et al.,
2011). It remains to be determined if
this plasticity reflects transformation
of rare multipotent cells within luminal
and basal/ME lineages, transforming
genetic events that influence differen-
tiation, or a combination of factors.REFERENCES
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